Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael U. Callaghan is active.

Publication


Featured researches published by Michael U. Callaghan.


Developmental Cell | 2008

UPR Pathways Combine to Prevent Hepatic Steatosis Caused by ER Stress-Mediated Suppression of Transcriptional Master Regulators

D. Thomas Rutkowski; Jun Wu; Sung Hoon Back; Michael U. Callaghan; Sean P. Ferris; Jahangir Iqbal; Robert Clark; Hongzhi Miao; Justin R. Hassler; Jamie L. Fornek; Michael G. Katze; M. Mahmood Hussain; Benbo Song; Jayanth Swathirajan; Junying Wang; Grace D.-Y. Yau; Randal J. Kaufman

The unfolded protein response (UPR) is linked to metabolic dysfunction, yet it is not known how endoplasmic reticulum (ER) disruption might influence metabolic pathways. Using a multilayered genetic approach, we find that mice with genetic ablations of either ER stress-sensing pathways (ATF6alpha, eIF2alpha, IRE1alpha) or of ER quality control (p58(IPK)) share a common dysregulated response to ER stress that includes the development of hepatic microvesicular steatosis. Rescue of ER protein processing capacity by the combined action of UPR pathways during stress prevents the suppression of a subset of metabolic transcription factors that regulate lipid homeostasis. This suppression occurs in part by unresolved ER stress perpetuating expression of the transcriptional repressor CHOP. As a consequence, metabolic gene expression networks are directly responsive to ER homeostasis. These results reveal an unanticipated direct link between ER homeostasis and the transcriptional regulation of metabolism, and suggest mechanisms by which ER stress might underlie fatty liver disease.


Archive | 2013

Selective small molecule activator of the apoptotic arm of the UPR

Daniel P. Flaherty; Jennifer E. Golden; Chunjing Liu; Michael Hedrick; Palak Gosalia; Yujie Li; Monika Milewski; Eliot Sugarman; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; Jena Diwan; Thomas Dy Chung; Anthony B. Pinkerton; Jeffrey Aubé; Justin R. Miller; Danielle M. Garshott; Michael U. Callaghan; Andrew M. Fribley; Randal J. Kaufman


Archive | 2013

Figure A6E, LCMS purity data at 214 nm for ML291 2nd batch –submitted to the MLSMR (SID 134228465, CID 52940465); LCMS retention time: 3.125 min; purity at 214 nm = 97.5%

Daniel P. Flaherty; Jennifer E. Golden; Chunjing Liu; Michael Hedrick; Palak Gosalia; Yujie Li; Monika Milewski; Eliot Sugarman; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; Jena Diwan; Thomas Dy Chung; Anthony B. Pinkerton; Jeffrey Aubé; Justin R. Miller; Danielle M. Garshott; Michael U. Callaghan; Andrew M. Fribley; Randal J. Kaufman


Archive | 2013

Figure 2, Chemical stability of ML291, represented by percent of parent remaining over time, in the presence of five-fold molar equivalent of GSH or DTT, incubated at room temperature in 1:1 ACN:PBS, pH 7.4, 1% (v/v) DMSO

Daniel P. Flaherty; Jennifer E. Golden; Chunjing Liu; Michael Hedrick; Palak Gosalia; Yujie Li; Monika Milewski; Eliot Sugarman; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; Jena Diwan; Thomas Dy Chung; Anthony B. Pinkerton; Jeffrey Aubé; Justin R. Miller; Danielle M. Garshott; Michael U. Callaghan; Andrew M. Fribley; Randal J. Kaufman


Archive | 2013

Table 3, Summary of in vitro ADME Properties of UPR CHOP Activator probe ML291

Daniel P. Flaherty; Jennifer E. Golden; Chunjing Liu; Michael Hedrick; Palak Gosalia; Yujie Li; Monika Milewski; Eliot Sugarman; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; Jena Diwan; Thomas Dy Chung; Anthony B. Pinkerton; Jeffrey Aubé; Justin R. Miller; Danielle M. Garshott; Michael U. Callaghan; Andrew M. Fribley; Randal J. Kaufman


Archive | 2013

Figure 4, Cellular Efficacy of ML291 for Activating the CHOP Pathway Induced cytotoxicity in MEF with wt-CHOP vs. CHOP-KO

Daniel P. Flaherty; Jennifer E. Golden; Chunjing Liu; Michael Hedrick; Palak Gosalia; Yujie Li; Monika Milewski; Eliot Sugarman; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; Jena Diwan; Thomas Dy Chung; Anthony B. Pinkerton; Jeffrey Aubé; Justin R. Miller; Danielle M. Garshott; Michael U. Callaghan; Andrew M. Fribley; Randal J. Kaufman


Archive | 2013

Figure A6C, LCMS purity data at 214 nm for ML291 1st batch (SID 123083137, CID 52940465); LCMS retention time: 3.074 min; purity at 214 nm = 95.4%

Daniel P. Flaherty; Jennifer E. Golden; Chunjing Liu; Michael Hedrick; Palak Gosalia; Yujie Li; Monika Milewski; Eliot Sugarman; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; Jena Diwan; Thomas Dy Chung; Anthony B. Pinkerton; Jeffrey Aubé; Justin R. Miller; Danielle M. Garshott; Michael U. Callaghan; Andrew M. Fribley; Randal J. Kaufman


Archive | 2013

Figure A6F, HRMS data for ML291 2nd batch –submitted to the MLSMR (SID 134228465, CID 52940465); HRMS m/z calculated for C16H17ClN3O6S [M + H+]: 414.0521, found 414.0522

Daniel P. Flaherty; Jennifer E. Golden; Chunjing Liu; Michael Hedrick; Palak Gosalia; Yujie Li; Monika Milewski; Eliot Sugarman; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; Jena Diwan; Thomas Dy Chung; Anthony B. Pinkerton; Jeffrey Aubé; Justin R. Miller; Danielle M. Garshott; Michael U. Callaghan; Andrew M. Fribley; Randal J. Kaufman


Archive | 2013

Figure 3, Activation of luciferase reporters driven by UPR sub-pathway promoters for the apoptotic (CHOP) and adaptive (XBP1) arms

Daniel P. Flaherty; Jennifer E. Golden; Chunjing Liu; Michael Hedrick; Palak Gosalia; Yujie Li; Monika Milewski; Eliot Sugarman; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; Jena Diwan; Thomas Dy Chung; Anthony B. Pinkerton; Jeffrey Aubé; Justin R. Miller; Danielle M. Garshott; Michael U. Callaghan; Andrew M. Fribley; Randal J. Kaufman


Archive | 2013

[Table], EXPERIMENTAL RESULTS FOR SID 123083137 ON OTHER TARGETS

Daniel P. Flaherty; Jennifer E. Golden; Chunjing Liu; Michael Hedrick; Palak Gosalia; Yujie Li; Monika Milewski; Eliot Sugarman; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Sumeet Salaniwal; Derek Stonich; Ying Su; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H. Smith; Jena Diwan; Thomas Dy Chung; Anthony B. Pinkerton; Jeffrey Aubé; Justin R. Miller; Danielle M. Garshott; Michael U. Callaghan; Andrew M. Fribley; Randal J. Kaufman

Collaboration


Dive into the Michael U. Callaghan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Angela Yang

University of Michigan

View shared research outputs
Top Co-Authors

Avatar

Benbo Song

University of Michigan

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Thomas Rutkowski

Roy J. and Lucille A. Carver College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Daniel P. Flaherty

Sanford-Burnham Institute for Medical Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge